Global Transcriptional Profiling Demonstrates the Combination of Type I and Type II Interferon Enhances Antiviral and Immune Responses at Clinically Relevant Doses-Reference-Cited by-同舟云学术

Global Transcriptional Profiling Demonstrates the Combination of Type I and Type II Interferon Enhances Antiviral and Immune Responses at Clinically Relevant Doses

Published:2005-10 Issue:10 Volume:25 Page:632-649
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

Tan Hua¹,Derrick Jena¹,Hong Jin¹,Sanda Corneliu²,Grosse William M.²,Edenberg Howard J.³,Taylor Milton²,Seiwert Scott¹,Blatt Lawrence M.¹

Affiliation:

1. InterMune Inc., Brisbane, CA 94005.

2. Department of Biology, Indiana University, Bloomington, IN 47401.

3. Department of Biochemistry and Molecular Biology and Center for Medical Genomics, Indiana University School of Medicine, Indianapolis, IN 46202-5122.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jir.2005.25.632

Reference72 articles.

1. The human interferon ? species and receptors

2. Review: IFN-α/βReceptor Interactions to Biologic Outcomes: Understanding the Circuitry

3. A Comparison of Interferon-Con1 with Natural Recombinant Interferons-α: Antiviral, Antiproliferative, and Natural Killer-Inducing Activities

4. THE IFNγ RECEPTOR:A Paradigm for Cytokine Receptor Signaling

5. The Molecular Cell Biology of Interferon-gamma and its Receptor

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG;BMC Cancer;2023-08-29

2. A co-formulation of Interferons alpha2b and gamma distinctively targets Cell Cycle in the glioblastoma-derived cell line U-87MG;2022-12-20

3. Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG;Cells;2022-12-15

4. HeberFERON distinctively targets Cell Cycle in the glioblastoma-derived cell line U-87MG;2022-09-23

5. IRF3 inhibits IFN‐γ‐mediated restriction of intracellular pathogens in macrophages independently of IFNAR;Journal of Leukocyte Biology;2021-11-26